This study examined the effect of oral glutamine (Gln) on radiation injury in breast cancer patients undergoing radiation therapy. The radiation injury was evaluated using Radiation Therapy Oncology Group (RTOG) scales. Cosmesis was scored. Blood Gln and glutathione (GSH) levels were determined. Serum protein profiling was determined using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Patients receiving Gln scored significantly better in RTOG score than the patients receiving placebo. Cosmetic scores averaged excellent in the Gln group vs fair to good in the placebo group. Blood Gln and GSH levels were significantly higher in the Gln group vs the placebo group. Serum protein profiling with SELDI-TOF MS identified a novel Gln-responsive protein that showed amino acid similarity with myoglobin. These results suggest that Gln is an effective way to reduce radiation morbidity to breast cancer and is associated with the increased expression of a novel serum protein biomarker.
RothE. Nonnutritive effects of glutamine. J Nutr. 2008;138(10):2025S-2031S.
2.
LabowBISoubaWW. Glutamine. World J Surg. 2000;24:1503-1513.
3.
MeisterAAndersonMA. Glutathione. Annu Rev Biochem. 1983;52:711.
4.
KosowerNSKosowerEM. The glutathione status of cells. Int Rev Cytol. 1978;54:109-156.
5.
SavareseDMSavyGVahdatL. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501-513.
6.
WelbourneT. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979;57:233-237.
7.
BongersTGriffithsRDMcArdleA. Exogenous glutamine: the clinical evidence. Crit Care Med. 2007;35(9)(suppl):S545-S552.
8.
KlimbergVS. Glutamine, cancer and its therapy. Am J Surg. 1996;172:418-424.
9.
TodorovaVKHarmsSAKaufmannY. Glutamine supplementation reduces glutathione levels and stimulates apoptosis in DMBA-induced mammary tumors. Breast Cancer Res Treat. 1994;88:247-256.
10.
RouseKNwokediEWoodliffJ. Glutamine enhances sensitivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995;221(4):420.
11.
FriezenCKiessYDebatinKM. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ. 2004;11(suppl 1):S73-S85.
12.
TormosCJavierCFGarciaMJ. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett. 2004;208(1):103-113.
13.
LopezMJPorterKA. Inflammatory breast cancer. Surg Clin North Am. 1996;76(2):411-429.
14.
HuntKKAmesFCSingletarySEBuzdarAUHortobagyiGN. Locally advanced noninflammatory breast cancer. Surg Clin North Am. 1996;76(2):393-409.
15.
CuzickJStewartHJPetoR. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Res. 1988;111:108-129.
16.
DoneganWLSprattJS. Cancer of the Breast. 4th ed.Philadelphia, PA: Saunders; 1995.
17.
NguyenDTKeastD. Energy metabolism and the skin. J Biochem. 1991;23(11):1175-1183.
18.
MansfieldCAKrishanmLKomarnickyLT. A review of the role of radiation therapy in the treatment of patients with breast cancer. Semin Oncol. 1991;18(6):525-535.
19.
MorrowMStromEABassettLW. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52(5):277-300.
20.
MendelsonEB. Evaluation of postoperative breast. Radiol Clin North Am. 1992;30:107-138.
21.
PetricoinEFOrnsteinDKLiottaLA. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol Oncol. 2004;22:322-328.
22.
ZieglerTRBenfellKSmithRJ. Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enteral Nutr. 1990;14(4)(suppl):137S-146S.
23.
NahorskiSR. Fluorometric measurement of glutamine and asparagine using enzymic methods. Anal Biochem. 1971;42:136-142.
24.
TietzeF. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ann Biochem. 1969;27:502-522.
25.
AndersonME. Enzymatic and chemical methods for the determination of glutathione. In: DolphinD, ed. Glutathione. Vol 1. New York: John Wiley; 1983.
26.
KohliMSiegelEBhattacharyaS. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer. Cancer Biomark. 2006;2(6):249-258.
27.
BhattacharyyaSSiegelERAchenbachSJ. Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. J Bone Miner Res. 2008;23(7):1106-1117.
28.
KlimbergVSSoubaWWDolsonDJ. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990;66(1):62-68.
29.
SuckauDCornettDS. Protein sequencing by ISD and PSD MALDI-TOF MS. Analusis. 1998;26:18-21.
30.
CaputoEMoharramRMartinBM. Methods for on-chip protein analysis. Anal Biochem. 2003;321(1):116-124.
31.
BrewisIABrennanP. Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol. 2010;80:1-44.
32.
BiaglowJEVarnesMEEppER. Role of glutathione and other thiols in the cellular response to radiation and drugs. Drug Metab Rev. 1989;20(1):1-12.
33.
ZhaoYSeefeldtTChenW. Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Radic Biol Med. 2009;47(2):176-183.
ZetterbergAEngstromW. Glutamine and the regulation of DNA replication and cell multiplication in fibroblasts. J Cell Physiol. 1978;95:41-48.
36.
Dall’AstaVRossiPBussolatiA. The transport of L-glutamine into cultured human fibroblasts. Biochim Biophys Acta. 1990;1052:106-112.
37.
ZielkeHROzandPTTildonJT. Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts. J Cell Physiol. 1978;95:41-48.
38.
ArchambeauJOPeznerRWassermanT. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995;31(5):1171-1185.
39.
NguyenDTKeastD. Energy metabolism and the skin. J Biochem. 1991;23(11):1175-1183.
40.
WhiteJJoinerMC. Toxicity from radiation in breast cancer. Cancer Treat Res. 2006;128:65-109.
41.
HarrisJRRechtA. Conservative surgery and radiotherapy. In: HarrisJRHellinaSHendersonIC, eds. Breast Disease. 2nd ed.Philadelphia, PA: JB Lippincott; 1991:395.
42.
BrownWDAkoyunoglouJA. Gamma-irradiation of purified myoglobin, I: effect on physicochemical properties. Arch Biochem Biophys. 1964;107:239.
43.
ClarkeRRichardsJF. Effect of gamma-irradiation on beef myoglobin. J Agric Food Chem. 1971;19(1):170-174.
44.
IyerSOlivaresJ. Trypsin digestion of proteins on intact immobilized pH gradient strips for surface matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Rapid Commun Mass Spectrom. 2003;17(20):2323-2326.
45.
WittenbergJBWittenbergBA. Myoglobin function reassessed. J Exp Biol. 2003;206:2011-2020.
46.
GarryDJMammenPP. Molecular insights into the functional role of myoglobin. Adv Exp Med Biol. 2007;618:181-193.
47.
BurmesterTGerlachFHankelnT. Regulation and role of neuroglobin and cytoglobin under hypoxia. Adv Exp Med Biol. 2007;618: 169-180.
48.
GalluzzoMPennacchiettiSRosanoS. Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J Clin Invest. 2009;119:865-875.
49.
DangCVKimJWGaoP. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8:51-56.
DewhirstMWCaoYMoellerB. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008;8:425-437.
52.
FlögelULaussmannTGödeckeA. Lack of myoglobin causes a switch in cardiac substrate selection. Circ Res. 2005;96(8):e68-e75.
53.
GlosterJHarrisP. Fatty acid binding to cytoplasmic proteins of myocardium and red and white skeletal muscle in the rat: a possible new role for myoglobin. Biochem Biophys Res Commun. 1977;74:506-513.
54.
SriramRKreutzerUShihL. Interaction of fatty acid with myoglobin. FEBS Lett. 2008;582(25-26):3643-3649.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
